Antipsychotic drugs: a concise review of history, classification, indications, mechanism, efficacy, side effects, dosing, and clinical application

S Leucht, J Priller, JM Davis - American Journal of Psychiatry, 2024 - psychiatryonline.org
The introduction of the first antipsychotic drug, chlorpromazine, was a milestone for
psychiatry. The authors review the history, classification, indications, mechanism, efficacy …

[HTML][HTML] IUPHAR review: Drug Repurposing in Schizophrenia–An Updated Review of Clinical Trials

JK Zaki, J Tomasik, S Bahn - Pharmacological Research, 2025 - Elsevier
There is an urgent need for mechanistically novel and more efficacious treatments for
schizophrenia, especially those targeting negative and cognitive symptoms with a more …

Disability and Adverse Effects of Oral Versus Long-Acting Injectable Antipsychotics in Schizophrenia-Spectrum and Bipolar Disorder: A Comparison Based on Data …

A Rodolico, SF Aprile, P Cutrufelli, G Privitera… - Clinical Drug …, 2024 - Springer
Background Patients undergoing antipsychotic treatment for psychiatric disorders may
experience challenges in functioning, either stemming from the severity of the illness or from …

[HTML][HTML] Psychotropic Taxonomies: Constructing a Therapeutic Framework for Psychiatry

RA McCutcheon, P Cowen, MM Nour, T Pillinger - Biological Psychiatry, 2024 - Elsevier
Pharmacological interventions are a cornerstone of psychiatric practice. The taxonomies
used to classify these interventions influence the treatment and interpretation of psychiatric …

[HTML][HTML] Muscarinic receptor agonists and positive allosteric modulators in animal models of psychosis: protocol for a systematic review and meta-analysis

S Siafis, N Nomura, J Schneider-Thoma… - …, 2025 - pmc.ncbi.nlm.nih.gov
Background Muscarinic receptor agonism and positive allosteric modulation is a promising
mechanism of action for treating psychosis, not present in most D2R-blocking antipsychotics …

How antipsychotics work in schizophrenia: a primer on mechanisms

JM Meyer - CNS spectrums, 2024 - cambridge.org
Antipsychotics effective for schizophrenia approved prior to 2024 shared the common
mechanism of postsynaptic dopamine D2 receptor antagonism or partial agonism. Positive …